Medirom Healthcare Technologies Stock Probability Of Bankruptcy

MRM Stock

USD 3.39 0.23 7.28%

Medirom Healthcare's odds of distress is over 60% at the moment. It has an above-average probability of going through some form of financial crunch in the next 2 years. Medirom Healthcare's Odds of distress is determined by interpolating and adjusting Medirom Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Medirom balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Medirom Healthcare Piotroski F Score and Medirom Healthcare Altman Z Score analysis.

As of the 29th of November 2024, Market Cap is likely to grow to about 5.8 B. Also, Enterprise Value is likely to grow to about 7.7 B

Medirom Healthcare Technologies Company odds of distress Analysis

Medirom Healthcare's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Medirom Healthcare Probability Of Bankruptcy

Over 60%

Most of Medirom Healthcare's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medirom Healthcare Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Medirom Healthcare probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Medirom Healthcare odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Medirom Healthcare Technologies financial health.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.582

Earnings Share

(0.15)

Revenue Per Share

1.4 K

Quarterly Revenue Growth

(0.06)

Return On Assets

(0.04)

The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Total Liab	Net Invested Capital	Long Term Investments	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Deferred Long Term Liab
Total Assets		0.32	-0.71	-0.68	-0.14	-0.25	0.33	0.96	-0.32	0.89	-0.91	0.96	0.85	0.14	-0.33	0.9	0.38	-0.05	-0.6	0.85	0.38	-0.56	-0.58
Total Stockholder Equity	0.32		0.39	0.05	-0.56	0.12	-0.55	0.1	-0.43	0.03	-0.08	0.05	0.7	-0.67	-0.03	0.53	0.22	0.62	-0.3	0.19	0.22	-0.75	-0.23
Net Tangible Assets	-0.71	0.39		0.7	-0.38	0.24	-0.8	-0.8	-0.17	-0.86	0.82	-0.87	-0.32	-0.66	0.19	-0.42	-0.12	0.64	0.35	-0.75	-0.12	0.03	0.49
Current Deferred Revenue	-0.68	0.05	0.7		0.3	0.73	-0.75	-0.7	-0.01	-0.85	0.57	-0.73	-0.27	0.01	0.72	-0.67	-0.71	0.13	0.83	-0.45	-0.71	0.19	0.2
Net Debt	-0.14	-0.56	-0.38	0.3		0.51	0.34	-0.07	0.66	0.01	-0.15	0.01	-0.18	0.9	0.6	-0.53	-0.71	-0.87	0.67	0.23	-0.71	0.45	-0.19
Retained Earnings	-0.25	0.12	0.24	0.73	0.51		-0.47	-0.36	0.01	-0.48	0.0	-0.31	0.09	0.25	0.98	-0.39	-0.94	-0.28	0.56	0.19	-0.94	-0.23	-0.49
Accounts Payable	0.33	-0.55	-0.8	-0.75	0.34	-0.47		0.42	0.57	0.67	-0.43	0.51	-0.13	0.51	-0.37	0.12	0.26	-0.69	-0.33	0.34	0.26	0.31	-0.1
Long Term Debt	0.96	0.1	-0.8	-0.7	-0.07	-0.36	0.42		-0.31	0.9	-0.89	0.99	0.72	0.29	-0.42	0.84	0.41	-0.1	-0.53	0.76	0.41	-0.35	-0.45
Net Receivables	-0.32	-0.43	-0.17	-0.01	0.66	0.01	0.57	-0.31		0.04	0.21	-0.21	-0.41	0.46	0.13	-0.54	-0.21	-0.7	0.4	-0.11	-0.21	0.58	0.22
Good Will	0.89	0.03	-0.86	-0.85	0.01	-0.48	0.67	0.9	0.04		-0.79	0.93	0.59	0.29	-0.48	0.72	0.49	-0.28	-0.58	0.75	0.49	-0.27	-0.4
Short Term Investments	-0.91	-0.08	0.82	0.57	-0.15	0.0	-0.43	-0.89	0.21	-0.79		-0.93	-0.72	-0.41	0.06	-0.73	-0.04	0.35	0.44	-0.91	-0.04	0.45	0.73
Total Liab	0.96	0.05	-0.87	-0.73	0.01	-0.31	0.51	0.99	-0.21	0.93	-0.93		0.7	0.35	-0.35	0.8	0.34	-0.23	-0.55	0.83	0.34	-0.37	-0.54
Net Invested Capital	0.85	0.7	-0.32	-0.27	-0.18	0.09	-0.13	0.72	-0.41	0.59	-0.72	0.7		-0.05	-0.05	0.82	0.16	0.18	-0.35	0.74	0.16	-0.72	-0.58
Long Term Investments	0.14	-0.67	-0.66	0.01	0.9	0.25	0.51	0.29	0.46	0.29	-0.41	0.35	-0.05		0.34	-0.25	-0.49	-0.84	0.46	0.38	-0.49	0.45	-0.22
Short Long Term Debt	-0.33	-0.03	0.19	0.72	0.6	0.98	-0.37	-0.42	0.13	-0.48	0.06	-0.35	-0.05	0.34		-0.52	-0.97	-0.4	0.59	0.16	-0.97	-0.13	-0.46
Total Current Assets	0.9	0.53	-0.42	-0.67	-0.53	-0.39	0.12	0.84	-0.54	0.72	-0.73	0.8	0.82	-0.25	-0.52		0.59	0.32	-0.76	0.6	0.59	-0.64	-0.4
Capital Stock	0.38	0.22	-0.12	-0.71	-0.71	-0.94	0.26	0.41	-0.21	0.49	-0.04	0.34	0.16	-0.49	-0.97	0.59		0.5	-0.68	-0.1	1.0	-0.06	0.37
Net Working Capital	-0.05	0.62	0.64	0.13	-0.87	-0.28	-0.69	-0.1	-0.7	-0.28	0.35	-0.23	0.18	-0.84	-0.4	0.32	0.5		-0.25	-0.42	0.5	-0.31	0.37
Short Term Debt	-0.6	-0.3	0.35	0.83	0.67	0.56	-0.33	-0.53	0.4	-0.58	0.44	-0.55	-0.35	0.46	0.59	-0.76	-0.68	-0.25		-0.39	-0.68	0.59	0.34
Intangible Assets	0.85	0.19	-0.75	-0.45	0.23	0.19	0.34	0.76	-0.11	0.75	-0.91	0.83	0.74	0.38	0.16	0.6	-0.1	-0.42	-0.39		-0.1	-0.61	-0.89
Common Stock	0.38	0.22	-0.12	-0.71	-0.71	-0.94	0.26	0.41	-0.21	0.49	-0.04	0.34	0.16	-0.49	-0.97	0.59	1.0	0.5	-0.68	-0.1		-0.06	0.37
Property Plant Equipment	-0.56	-0.75	0.03	0.19	0.45	-0.23	0.31	-0.35	0.58	-0.27	0.45	-0.37	-0.72	0.45	-0.13	-0.64	-0.06	-0.31	0.59	-0.61	-0.06		0.74
Deferred Long Term Liab	-0.58	-0.23	0.49	0.2	-0.19	-0.49	-0.1	-0.45	0.22	-0.4	0.73	-0.54	-0.58	-0.22	-0.46	-0.4	0.37	0.37	0.34	-0.89	0.37	0.74

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	0.003644	(0.0944)	(0.17)	0.0221	0.0168	0.0176
Asset Turnover	0.82	0.58	0.94	1.03	1.0	0.69
Net Debt	1.8B	463.8M	2.4B	1.9B	3.5B	2.3B
Total Current Liabilities	2.3B	2.7B	3.2B	3.6B	3.6B	3.2B
Non Current Liabilities Total	1.9B	2.6B	2.8B	3.2B	3.1B	2.9B
Total Assets	4.8B	5.7B	5.8B	6.7B	6.8B	6.3B
Total Current Assets	1.4B	2.1B	1.4B	2.4B	1.8B	1.8B
Total Cash From Operating Activities	7.9M	(366.4M)	(557.2M)	(685.7M)	(631.7M)	(600.2M)

	Return On Equity	1.47
	Return On Asset	-0.036
	Profit Margin	0.02 %
	Operating Margin	(0.02) %
	Current Valuation	38.3 M
	Shares Outstanding	5.04 M
	Shares Owned By Insiders	40.37 %
	Number Of Shares Shorted	49.15 K
	Price To Book	13.24 X
	Price To Sales	0 X
	Revenue	6.83 B
	Gross Profit	1.42 B
	EBITDA	310.08 M
	Net Income	115.05 M
	Cash And Equivalents	354.95 M
	Cash Per Share	72.70 X
	Total Debt	3.65 B
	Current Ratio	0.36 X
	Book Value Per Share	43.19 X
	Cash Flow From Operations	(631.74 M)
	Short Ratio	0.71 X
	Earnings Per Share	(0.15) X
	Number Of Employees	390
	Beta	0.009
	Market Capitalization	15.93 M
	Total Asset	6.85 B
	Retained Earnings	80.28 M
	Working Capital	(1.8 B)
	Net Asset	6.85 B

Medirom Healthcare Technologies Stock Probability Of Bankruptcy

Medirom Healthcare Technologies Company odds of distress Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Medirom Healthcare Probability Of Bankruptcy

Medirom Probability Of Bankruptcy Driver Correlations

Medirom Probability Of Bankruptcy Peer Comparison

Medirom Healthcare Main Bankruptcy Drivers

Medirom Healthcare ESG Sustainability

Medirom Fundamentals

About Medirom Healthcare Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY